Criar novo Painel
EMPRESARIAL
Imagens Editorial

Abbott To Sell Generic Drug Unit To Mylan For $5.3 Billion

Employees walk near an Abbott Laboratories sign at the company's headquarters complex in Abbott Park, Illinois, U.S., on Monday, July 14, 2014. Abbott Laboratories said it plans to sell its generic drug business for established markets to Mylan Inc., getting in return a share of the newly combined companies in a deal valued at about $5.3 billion. Photographer: Daniel Acker/Bloomberg via Getty Images
Abbott To Sell Generic Drug Unit To Mylan For $5.3 Billion
Incorporar esta imagem

DETALHES

Restrições:
Contacte o representante local para todos os usos comerciais ou promocionais.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Crédito:
Bloomberg / Colaborador
Editorial #:
452152892
Coleção:
Bloomberg
Data da criação:
14 de julho de 2014
Tipo de licença:
Inf. sobre autorização:
Não tem autorização. Mais informações
Fonte:
Bloomberg
Nome do objeto:
ABBOTT MYLAN